Johnson & Johnson vs Wells Fargo & Co — how do they compare? Johnson & Johnson trades at $250.8 (market cap $598.96B), while Wells Fargo & Co trades at $87.9 (market cap $261.45B). The key difference: Johnson & Johnson is far larger — about 2.3× Wells Fargo & Co's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.
| JNJ | WFC | |
|---|---|---|
Market Cap | $598.96B | $261.45B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $96.40 |
52-Week Low | $164.36 | $73.42 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | 2.09% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →